Value in Health Regional Issues 4 C (2014) 37-40
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
Standard Operating Procedures for Implementation of TB Activities at HIV/AIDS Service Delivery Sites
Good practice guide
Supporting community action on HIV, health and rights to end AIDS
Networking for Policy Change: TB/HIV Participant’s Guide
WHO/HTM/TB/2007.384b
“TB is too often a death sentence for people with AIDS. It does not have to be this
way.”
-Nelson Mandela, International conference on HIV and AIDS, Bangkok, Thailand, July 2004.
Working Document, September 2017
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
Hindawi Publishing Corporation
Tuberculosis Research and Treatment
Volume 2015, Article ID 752709, 7 pages
Blueprint for EECA countries, first edition
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Medicina (Kaunas) 2013;49(7):335-40